VERA (Vera Therapeutics Inc) Sof foyda

VERA (Vera Therapeutics) - kompaniyaning tovar belgisi

Vera Therapeutics, Inc. (VERA) barqaror ta'minotni ta'minlash uchun global pudratchilar bilan hamkorlikdan foydalangan holda buyrak terapiyalarini ishlab chiqadi. GURU.Markets platformasidagi ushbu narxlar grafigi biznesning tartibga soluvchi qarorlar va sinovlar muvaffaqiyatiga bog'liqligini ko'rsatadi, foyda ko'rsatkichi esa -0.40 darajasida turibdi. Tadqiqot va ishlanmalar (R&D) bo'yicha ekspertlarning kuchli jamoasi barqarorlikni ta'minlaydi, ammo kompaniya o'zining ilmiy asoslarini himoya qilish uchun noyob klinik mutaxassislarni qidirishda davom etmoqda.

VERA (Vera Therapeutics, Inc.) Sof foyda tarixi 04.07.2022dan 01.11.2026gacha

Vera Therapeutics (VERA) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Vera Corp|VERA - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Vera Corp|VERA - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Vera Therapeutics|VERA - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi veratx.com|VERA - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Vera Therapeutics, Inc.|VERA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Vera Therapeutics Inc|VERA - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Vera Corp|VERA - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Vera Therapeutics|Shoshilinch likvidlik veratx.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
VERA - Sof daromad
Kompaniyaning jamlanma tahlili:Vera Therapeutics, Inc.
Vera Pharma asosiy tovari

Ushbu ko'rsatkich umumiy daromadlar va barcha operatsion xarajatlar orasidagi farq sifatida hisoblanadi hamda xarajatlar qoplanganidan keyingi naqd pul generatsiyasining haqiqiy samaradorligini o'lchaydi. Vera Therapeutics, Inc. (VERA) uchun ushbu balans kompaniyaning o'ziga tegishli buyrak kasalliklari dvorisining ishlab chiqish xarajatlariga bog'liq. Kompaniyaning sof operatsion foydasidagi mahalliy pasayishlar tadqiqot va ishlanmalar (R&D) investitsiyalarining oshganligidan dalolat beradi. Ushbu egri chiziqni tahlil qilish kirish xarajatlarini aktivlar qiymatini kamaytirish xatarlari bilan muvozanatlashga yordam beradi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Dianthus Corp|Kompaniyaning sof foydasi Pharvaris N.V. (PHVS)|AbCellera Biologics Inc. - Kompaniya foydasi|Sof foyda TRML (Tourmaline Bio)|Precigen Inc (PGEN) - Kompaniyaning sof daromadi|PHAR: Sof daromad|NKTR: Kompaniyaning sof foydasi|UPB: Sof foyda|Kompaniyaning sof daromadi zenasbio.com (ZBIO)|Kompaniyaning sof foydasi Immunome|GOSS: Yakuniy foyda|Sof foyda KALV|Sof foyda Septerna Pharma (SEPN)|Pieris Pharmaceuticals - Sof daromad|Yakuniy foyda SVRA|RIGL: Sof daromad|AnaptysBio Inc - Soliqlar to‘langandan keyingi foyda|ATXS: Sof foyda|enGene Corp - Yakuniy foyda|RAPT (RAPT Therapeutics, Inc.) - Sof foyda|Kompaniyaning sof daromadi Aerovate JBIO|Kompaniyaning sof foydasi Aclaris Therapeutics, Inc. (ACRS)|KYTX (Kyverna Therapeutics Inc.) - Yakuniy foyda|Sof foyda TLSA (Tiziana Life Sciences PLC)|Sof foyda Cabaletta Bio Inc CABA|VTYX - Kompaniyaning sof foydasi|Soliqdan keyingi foyda THTX|AVTX: Sof foyda|Kompaniyaning sof daromadi Eledon Pharmaceuticals Inc. (ELDN)|Sof daromad AGEN|Sof foyda Climb Bio, Inc|Sof daromad ZURA (Zura Bio Limited)|Soliqlar to‘langandan keyingi foyda ATYR|Sof foyda ADAG (Adagene Inc.)|Sof moliyaviy natija ImageneBio (IMA)|Shattuck Therapeutics - Sof foyda|Equillium, Inc. (EQ) - Sof daromad|connectbiopharm.com (CNTB) - Kompaniyaning sof foydasi|IMUX - Sof moliyaviy natija|Sof daromad ATRA|IFRX: Yakuniy foyda|Sof foyda XFOR|Sof moliyaviy natija adicetbio.com|Kompaniyaning sof foydasi Celularity CELU|INMB: Kompaniya foydasi|Barinthus Biotherapeutics plc - Sof foyda|Kezar Life Sciences Inc. (KZR) - Sof daromad|SABS (SAB Biotherapeutics, Inc) - Sof daromad|AKTX - Sof moliyaviy natija|Sof daromad ENLV|Kompaniyaning sof foydasi QTTB|Sof foyda GOVX|EDSA - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi iBio Corp IBIO|Yakuniy foyda CARM|XTL Biopharmaceuticals - Sof foyda|BOLT - Sof foyda|hcwbiologics.com (HCWB) - Kompaniyaning sof foydasi|Soliqdan keyingi foyda APVO (Aptevo Therapeutics Inc.)|AIM (AIM ImmunoTech) - Sof foyda|ADTX: Yakuniy foyda|Sof foyda GRI|Sof foyda xortx.com (XRTX)|Kompaniyaning sof foydasi Vyome Holdings HIND|Yakuniy foyda REVB|INDP - Kompaniyaning sof foydasi|BiondVax Pharmaceuticals (SCNI) - Sof daromad|CALI: Sof foyda|Affimed N.V. (AFMD) - Sof foyda|Sof daromad ALLK|HOOK: Yakuniy foyda|Sof foyda IGMS|Sof moliyaviy natija iTeos Pharma|Kompaniyaning sof foydasi Ocean Biomedical, Inc. OCEA|TCBP - Sof daromad|THRD - Kompaniyaning sof foydasi